Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hippel-Lindau Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Not applicableActive Not RecruitingNCT05737602
What this trial is testing

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseGenetic Disorder
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT01436227
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 32
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Very early researchEnded earlyNCT01015300
What this trial is testing

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Who this might be right for
HemangioblastomasVon Hippel Lindau Disease
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT00088374
What this trial is testing

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Who this might be right for
Hippel-Lindau DiseaseKidney Cancer
National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Not applicableNot Yet RecruitingNCT07554508
What this trial is testing

Belzutifan VHL RCC HK Prospective Registry

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
Chinese University of Hong Kong 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03401788
What this trial is testing

Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

Who this might be right for
VHL - Von Hippel-Lindau SyndromeVHL Gene MutationVHL Syndrome+3 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 50
Not applicableNot Yet RecruitingNCT07705529
What this trial is testing

Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System Hemangioblastomas

Who this might be right for
Von Hippel-Lindau DiseaseCentral Nervous System Hemangioblastoma
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Ended earlyNCT00673816
What this trial is testing

Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 2
Testing effectiveness (Phase 2)Ended earlyNCT00330564
What this trial is testing

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Who this might be right for
Von Hippel-Lindau SyndromeRenal Cell CarcinomaHemangioblastoma
M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT03749980
What this trial is testing

MyVHL: Patient Natural History Study

Who this might be right for
Von Hippel-Lindau DiseaseHereditary Leiomyomatosis and Renal Cell CancerBirt-Hogg-Dube Syndrome+1 more
Joshua Mann, MPH 10,000
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Not applicableLooking for participantsNCT00001238
What this trial is testing

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Who this might be right for
Kidney CancerUrologic Malignant DisordersRenal Cell Carcinoma+2 more
National Cancer Institute (NCI) 5,000
Early research (Phase 1)Study completedNCT00089765
What this trial is testing

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Study completedNCT00052013
What this trial is testing

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Who this might be right for
Von Hippel-Lindau DiseaseCNS HemangioblastomaRetinal Hemangioblastoma
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Looking for participantsNCT04074135
What this trial is testing

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Who this might be right for
VHL Pancreatic Neuroendocrine TumorsVon Hippel-Lindau DiseaseNeuroendocrine Tumors
National Cancer Institute (NCI) 740
Next Page
355